The global cephalosporin market size was worth US$ 11.4 Billion in 2018. Cephalosporins are beta-lactam antibiotics that function in the way similar to penicillin. These broad-spectrum drugs help in treating numerous bacterial infections such as pneumonia, kidney infections, bone infections, meningitis and various sexually transmitted diseases (STDs). There are currently five generations of cephalosporin drugs available in the market with a slight difference in their antibacterial spectrum. These medicines are also differentiated on the basis their administration, excretion, absorption and the duration of the effect of cephalosporin on the body. There are two ways to administer cephalosporin drugs, namely, oral and intravenous (IV). A course of oral cephalosporins is generally used for curing minor infections that are easy to treat such as strep throat. Whereas, IVs are utilized for more severe infections, like meningitis, as these medicines reach tissues quickly than those administered orally.
At present, the rapidly increasing water and air pollution are the primary reasons for the prevalence of infectious diseases across the globe. This has provided a boost to the demand for cephalosporin drugs worldwide. Other than this, various organizations around the world are taking initiatives to improve the development and delivery of antibiotic treatments. One such program is the Global Antibiotic Research and Development Partnership (GARDP), which is a not-for-profit R&D organization formed by the Drugs for Neglected Disease initiative (DNDi) and World Health Organization (WHO). It focusses on the promotion of public-private partnerships for increasing R&D of new antimicrobial diagnostics and agents. The formation of these partnerships is expected to play a significant role in the growth of the cephalosporin market. Looking forward, IMARC Group expects the market to reach a value of US$ 13.3 Billion by 2024, registering a CAGR of around 3% during 2019-2024.
Report Coverage:
- Historical, Current and Future Market Trends
- Market Breakup by Generation:
- First Generation
- Second Generation
- Third Generation
- Fourth Generation
- Fifth Generation
- Market Breakup by Route of Administration:
- Market Breakup by Application:
- Respiratory Tract
- Skin Infection
- Ear Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Others
- Market Breakup by Region:
- Asia Pacific
- Europe
- North America
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Limited (Lupin Pharmaceuticals, Inc., Merck & Co. Inc., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Abbott, Ranbaxy, Merck, etc.
Key Questions Answered in This Report:
- How has the global cephalosporin market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global cephalosporin industry?
- What is the breakup of the market based on the generation?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the global cephalosporin industry?
- What are the key driving factors and challenges in the global cephalosporin industry?
- What is the structure of the global cephalosporin industry and who are the key players?
- What is the degree of competition in the global cephalosporin industry?
- What are the profit margins in the global cephalosporin industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cephalosporin Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Generation
5.4 Market Breakup by Route of Administration
5.5 Market Breakup by Application
5.6 Market Breakup by Region
5.7 Market Forecast
6 Market Breakup by Generation
6.1 First Generation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Second Generation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Third Generation
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Fourth Generation
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Fifth Generation
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Injection
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Respiratory Tract
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Skin Infection
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ear Infection
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Urinary Tract Infection
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Sexually Transmitted Infection
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Region
9.1 Asia Pacific
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Europe
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 North America
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Allergan Plc.
14.3.2 Bristol-Myers Squibb Company
14.3.3 F. Hoffmann-La Roche Ltd.
14.3.4 GlaxoSmithKline plc
14.3.5 Lupin Limited (Lupin Pharmaceuticals, Inc.
14.3.6 Merck & Co. Inc.
14.3.7 Novartis International AG (Sandoz)
14.3.8 Pfizer Inc.
14.3.9 Teva Pharmaceutical Industries Ltd.
14.3.10 Abbott
14.3.11 Ranbaxy
14.3.12 Merck
List of Figures
Figure 1: Global: Cephalosporin Market: Major Drivers and Challenges
Figure 2: Global: Cephalosporin Market: Sales Value (in Billion US$), 2013-2018
Figure 3: Global: Cephalosporin Market: Breakup by Generation (in %), 2018
Figure 4: Global: Cephalosporin Market: Breakup by Route of Administration (in %), 2018
Figure 5: Global: Cephalosporin Market: Breakup by Application (in %), 2018
Figure 6: Global: Cephalosporin Market: Breakup by Region (in %), 2018
Figure 7: Global: Cephalosporin Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 8: Global: Cephalosporin (First Generation) Market: Sales Value (in Million US$), 2013-2018
Figure 9: Global: Cephalosporin (First Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 10: Global: Cephalosporin (Second Generation) Market: Sales Value (in Million US$), 2013-2018
Figure 11: Global: Cephalosporin (Second Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 12: Global: Cephalosporin (Third Generation) Market: Sales Value (in Million US$), 2013-2018
Figure 13: Global: Cephalosporin (Third Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 14: Global: Cephalosporin (Fourth Generation) Market: Sales Value (in Million US$), 2013-2018
Figure 15: Global: Cephalosporin (Fourth Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 16: Global: Cephalosporin (Fifth Generation) Market: Sales Value (in Million US$), 2013-2018
Figure 17: Global: Cephalosporin (Fifth Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Global: Cephalosporin (Injection) Market: Sales Value (in Million US$), 2013-2018
Figure 19: Global: Cephalosporin (Injection) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 20: Global: Cephalosporin (Oral) Market: Sales Value (in Million US$), 2013-2018
Figure 21: Global: Cephalosporin (Oral) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 22: Global: Cephalosporin (Respiratory Tract) Market: Sales Value (in Million US$), 2013-2018
Figure 23: Global: Cephalosporin (Respiratory Tract) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 24: Global: Cephalosporin (Skin Infection) Market: Sales Value (in Million US$), 2013-2018
Figure 25: Global: Cephalosporin (Skin Infection) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 26: Global: Cephalosporin (Ear Infection) Market: Sales Value (in Million US$), 2013-2018
Figure 27: Global: Cephalosporin (Ear Infection) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 28: Global: Cephalosporin (Urinary Tract Infection) Market: Sales Value (in Million US$), 2013-2018
Figure 29: Global: Cephalosporin (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 30: Global: Cephalosporin (Sexually Transmitted Infection) Market: Sales Value (in Million US$), 2013-2018
Figure 31: Global: Cephalosporin (Sexually Transmitted Infection) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 32: Global: Cephalosporin (Other Applications) Market: Sales Value (in Million US$), 2013-2018
Figure 33: Global: Cephalosporin (Other Applications) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 34: Asia Pacific: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
Figure 35: Asia Pacific: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 36: Europe: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
Figure 37: Europe: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 38: North America: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
Figure 39: North America: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 40: Middle East and Africa: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
Figure 41: Middle East and Africa: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 42: Latin America: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
Figure 43: Latin America: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
List of Tables
Table 1: Global: Cephalosporin Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: Cephalosporin Market Forecast: Breakup by Generation (in Million US$), 2019-2024
Table 3: Global: Cephalosporin Market Forecast: Breakup by Route of Administration (in Million US$), 2019-2024
Table 4: Global: Cephalosporin Market Forecast: Breakup by Application (in Million US$), 2019-2024
Table 5: Global: Cephalosporin Market Forecast: Breakup by Region (in Million US$), 2019-2024
Table 6: Global: Cephalosporin Market Structure
Table 7: Global: Cephalosporin Market: Key Players